Aug. 2, 2002 -- Long-term continuous combination therapy with 17beta-estradiol and norethisterone acetate over five years was not associated with either endometrial hyperplasia or cancer ...

Starton Therapeutics Inc., a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, announced that it notified ...

The conditions to the closing of the initial business combination and subsequent amendments were not satisfied or waived by the outside date of November 3 2023 (the “Termination”).